Source: ERJ Open Res, 7 (3) 00902-2020; 10.1183/23120541.00902-2020
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Emily P. Brigham, Julie A. Anderson, Robert D. Brook, Peter M.A. Calverley, Bartolome R. Celli, Nicholas J. Cowans, Courtney Crim, James E. Diserens, Fernando J. Martinez, Meredith C. McCormack, David E. Newby, Julie Yates, Jorgen Vestbo, Tianshi David Wu, Robert A. Wise. Challenging the obesity paradox: extreme obesity and COPD mortality in the SUMMIT trial. ERJ Open Res, 7 (3) 00902-2020; 10.1183/23120541.00902-2020

Member's Comments

No comment yet.

Related content which might interest you: Late-breaking abstract: A prospective study of central obesity, overall obesity and incident asthma in adults Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 Childhood obesity in relation to poor asthma control and exacerbation: a meta-analysis Source: Eur Respir J 2016; 48: 1063-1073 Year: 2016 Sarcopenia, systemic immune-inflammation index and all-cause mortality in middle-aged and older people with COPD and asthma: a population-based study Source: ERJ Open Res, 8 (1) 00628-2021; 10.1183/23120541.00628-2021 Year: 2022 Obesity and asthma: evidence for and against a causal relation Source: Annual Congress 2006 - Asthma in obesity: a new entity? Year: 2006 Obesity increases the risk of incident asthma among adults Source: Eur Respir J 2005; 25: 282-288 Year: 2005 Risk factors for all-cause mortality in patients with COPD: results from the ETHOS trial Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies Year: 2021 Obesity and risk of subsequent hospitalisation with pneumonia Source: Eur Respir J 2010; 36: 1330-1336 Year: 2010 Management of patients with asthma or COPD and cardiovascular disease: risks versus benefits Source: Eur Respir Monogr 2020; 88: 66-81 Year: 2020 Cardiovascular comorbidities in hospitalised COPD patients: a determinant of future risk? Source: Eur Respir J 2015; 46: 846-849 Year: 2015 NIV and obesity: in the long-term setting Source: ERS course 2015 Year: 2015 Impact of obesity on outcomes for patients hospitalised with pneumonia Source: Eur Respir J 2013; 41: 929-934 Year: 2013 Obesity, smoking and gender type as cardiovascular risk factors among COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 453s Year: 2007 Excess economic burden of comorbidities in COPD: a 15-year population-based study Source: Eur Respir J, 50 (1) 1700393; 10.1183/13993003.00393-2017 Year: 2017 Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD Source: Eur Respir J 2008; 32: 962-969 Year: 2008 Symptoms of COPD in the general population are associated with overweight and obesity Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013 The impact of overweight and obesity on acute exacerbations of COPD - subgroup analysis of the Taiwan obstructive lung disease cohort Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care Year: 2017 Overuse of short-acting ß2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme Source: Eur Respir J, 55 (4) 1901872; 10.1183/13993003.01872-2019 Year: 2020 Predictors of long-term mortality after hospitalization for COPD; A Scandinavian multicentre study Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014 Underweight and weight loss are assocaited with greater mortality from chronic obstructive pulmonary disease (COPD) in middle-aged Japanese: The JACC study Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) Year: 2018 Obesity: a comorbidome of COPD Source: International Congress 2016 – Obesity and respiratory diseases Year: 2016